Omnicell (NASDAQ: OMCL)
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-07-28 | ||||||
REV |
Q1 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | 0.680 | 0.830 | 0.1500 | ||||
REV | 314.360M | 318.828M | 4.468M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Omnicell (NASDAQ: OMCL) through any online brokerage.
Other companies in Omnicell’s space includes: Masimo (NASDAQ:MASI), Envista Holdings (NYSE:NVST), Koninklijke Philips (NYSE:PHG), Inari Medical (NASDAQ:NARI) and Smith & Nephew (NYSE:SNN).
The latest price target for Omnicell (NASDAQ: OMCL) was reported by Wells Fargo on Tuesday, May 3, 2022. The analyst firm set a price target for 158.00 expecting OMCL to rise to within 12 months (a possible 36.95% upside). 7 analyst firms have reported ratings in the last year.
The stock price for Omnicell (NASDAQ: OMCL) is $115.37 last updated July 1, 2022, 8:00 PM UTC.
There are no upcoming dividends for Omnicell.
Omnicell’s Q2 earnings are confirmed for Thursday, July 28, 2022.
There is no upcoming split for Omnicell.
Omnicell is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.